Research Article
Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom
Table 5
Base-case results for direct comparison of cost-effectiveness of pazopanib versus placebo.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LYs: life-years; PFLYs: progression-free life-years; PFS: progression-free survival; PPLYs: postprogression life-years; PPS: postprogression survival; QALYs: quality-adjusted life-years. |